← Open Payments lookup

MICHELLE ALLEN: Open Payments

NPI 1922540822 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$819 in 28 payments from 13 companies in 2025. Trend: 2023 $80 · 2024 $0 · 2025 $819

Food & beverage: $819
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$282
GENZYME CORPORATION4$92
Novartis Pharmaceuticals Corporation3$86
CSL Behring2$61
ARS Pharmaceuticals Operations, Inc.3$58
Galderma Laboratories, L.P.2$50
ABBVIE INC.2$34
Organon LLC1$33
Paratek Pharmaceuticals, Inc.1$28
Grifols USA, LLC1$26

Products named: TEZSPIRE, Rhapsido, AIRSUPRA, DUPIXENT, Hizentra, NEFFY, NEMLUVIO, FASENRA.

Industry payments across TX — which companies pay providers there.